Analysis of pleural effusions using flow cytometry

Respiration

Volumn 63, Issue 1, 1996, Pages 17-24

  Ceyhan, Benrin Bağci ^a   Demiralp, Emel ^a   Çelikela, Turgay ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

DNA index; Flow cytometry; Mononuclear cell phenotyping; Pleural effusions

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE G2 PHASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DNA CONTENT; EMPYEMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOPROTEINEMIA; IMMUNOPHENOTYPING; LUNG CARCINOMA; LUNG EMBOLISM; LUNG SMALL CELL CANCER; LYMPHOMA; MALE; MESOTHELIOMA; METAPHASE; MONONUCLEAR CELL; NEUROBLASTOMA; OVARY CARCINOMA; PLEURA EFFUSION; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION;

EID: 0030048841     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000196510     Document Type: Article

References (43)

1. Vladuliu AO. Brason FW. Adler RH: Differential diagnosis of pleural effusions: Clinical usefulness of cell marker quantitation. Chest 1981:79:297-301.
2. Laerunt OD, Farsund T: Clinical application of flow cytometry: A review. Cytometry 1981:2: 1-13.
3. Barlogic B. Raher MN, Schumann J. Johnson TS. Drewinko B. Swartzendruber DE. Gohde W. Andreeff M, Freireich EJ: Flow cytometry in clinical cancer research. Cancer Res 1983: 43:3982-3997.
4. Dewald G. Dines DE. Weiland LH. Gordon H: Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. N Engl J Med 1976;259:1494-1500.
5. Vindelov LL, Christensen IJ: A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 1990:11:753-770.
6. Isobe H. Miyamoto H, Shimizu T. Haneda H. Hashimoto M. Inoue K, Mizuno S. Kawakami Y: Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990:65: 1391-1395.
7. Barlogic B. Gohde W. Johnston DA, Smallwood L. Schumann J, Drewinko B, Freireich EJ: Determination of ploidy and proliferative characteristics of human solid tumor by pulse cytophotometrv. Cancer Res 1978:38:3333-3339.
8. Barlogie B. Drewinko B. Schumann J, Gohde W, Dosik G. Latreille J. Johnston DA. Freireich EJ: Cellular DNA content as a marker of neoplasia in man. Am J Med 1980:69:195-203.
9. Rijkcn A, Dekker A, Taylor S. Hoffman P. Blank M. Krause JR: Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. Am J Clin Pathol 1991:95:6-12.
10. Schneller J. Eppich E, Grecnebaum F, Elequin F. Sherman A. Wersto R. Koss LG: Flow cytometry and Fculgen cytophotometry in evaluation of effusions. Cancer 1987:59:1307-1313.
11. Unger KM. Raber M, Bedrossian CWM. Stein DA, Barlogic B: Analysis of pleural effusions using automated flow cytometry. Cancer 1983: 52:873-877.
12. Hostmark J, Vigander T. Skaarland E: Characterization of pleural effusions by flow cytometric DNA analysis. Fur J Respir Dis 1985:66: 315-319.
13. Rabinowich H. Cohen R. Bruderntan I, Steiner Z, Klajman A: Functional analysis of mononuclear cells infiltrating into tumors, lysis of autologous tumour cells by cultured infiltrating lymphocytes. Cancer Res 1987:47:173-177.
14. −. J Immunol 1983:131: 2864-2867.
15. Bjemer L, Gronberg H. Roos G. Henriksson R: Interleukin-2 administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma: Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage. Biotherapy 1993: 6:1-7.
16. Guzman J. Brass KJ. Costabel U: Malignant lymphoma in pleural effusions: An immunocy-tochemical cell surface analysis. Diagn Cytopathol 1991:7:113-118.
17. Baserga R: The cell cycle. N Engl J Med 1981: 304:453-459.
18. Taylor SR. Titus-Ernstoff L. Stitely S: Central values and variation of measured nuclear DNA content in imprints of normal tissues determined bv image analysis. Cytometry 1989:10: 382-387.
19. Barnes PF. Mistry SD. Cooper CL. Pirmez C, Rea IH. Modlin RL: Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989:142:1114-1119.
20. Evans DA. Thomthwaite JT. Ng AB. Sugar-baker EV: DNA flow cytometry of pleural effusions. Anal Quant Cytol 1983:5:19-27.
21. Stonesifer KJ, Xiang JH. Wilkinson EJ, Benson NA, Braylan RC: Flow-cytomctric analysis and cytopathology of body cavity fluids. Acta Cytol 1987:31:125-130.
22. Medley DW. Philips J, Rugg CA: Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. Eur J Cancer Clin Oncol 1984:20:749-752.
23. Look AT, Roberson PK. Williams DL. Rivera G. Bowman WP. Pui CH. Ochs J. Abromo-witch M, Kalwinskv D. Dahl GV: Prognostic significance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood 1985:56:1079-1086.
24. Zimmerman PV. Hawson GAT. Bint MH, Parson PG: Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987;vol ii: 530-533.
25. Caulet S, Carpon F. Ghorra J. Brechot JM. Lebeau B, Diebold J: Flow cytometric DNA analysis of 20 bronchopulmonary neuroendocrine tumours. Eur Respir J 1993;6:83-89.
26. Moran R. Melamed MR: Flow cytometric analysis of human lung cancer: Correlation with histologic type and stage. Anal Quant Cytol Histol 1984;6:99-104.
27. Katz RL. Johnson TS. Williamson KD: Comparison of cytologic and acridine orange How cytometric detection of malignant cells in human bodv cavity fluids. Anal Quant Cvtol Histol 1985;7:227-235.
28. Sahri K. Tribukait B. Einhorn N: Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance. Gynecol Oncol 1989;35:240-245.
29. Frierson HF Jr, Mills SE. Lcgier JF: Flow cytometric analysis of ploidy in immunohisto-chemically confirmed examples of malignant epithelial mesothelioma. Am J Clin Pathol 1988:90:240-243.
30. Hafiz MA. Becker RL Jr, Mikel UV. Bahr GF: Cytophotontetric determination of DNA in mesotheliomas and reactive mésothélial cells. Anal Quant Cytol Histol 1988:10:120-126.
31. Albera C. Mabritto I. Ohio P. Scagligotti GV. Pozzi E: Lymphocyte subpopulation analysis in pleural fluid and peripheral blood in patients with lymphocytic pleural effusions. Respiration 1991:58:65-71.
32. Domagala W. Emeson EE. Koss LG: Distribution of T-lvmphocytes and B-lvmphocytes in peripheral blood and effusions in patients with cancer. J Natl Cancer Inst 1978;61:295-300.
33. Lucivero G, Pierucci G. Bonomo L: Lymphocyte subsets in peripheral blood and pleural fluid. EurRespir J 1988:1:337-340.
34. Guzman J. Bros KJ. Wurtemberger G. Costabel U: Immunocytology in malignant pleural mesothelioma. Chest 1989;95:590-595.
35. Kochman S, Bernard J. Lavaud F. Cazabat A. Dubois de Montreynaud JM: T lymphocte subsets in pleural fluids: Discrimination according to traditional and monoclonal antibody defined markers. Eur J Respir Dis 1984:65:586-591.
36. lakahashi K, Sone S. Kimura S. Ogura T, Monden Y: Phenotypes and lymphokine-acti-vated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusions. Chest 1993:103:1732-1738.
37. Guzman J. Brass KJ. Wurtemberger G. Freu-denberg N. Costabcl U: Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte rich effusions. Diagn Cytopathol 1989;5:139-144.
38. Berthier A. Bernard J. Bartal M. Benslimane A. Lavaud F. Kochman S: Tlymphocytes in the circulating blood and pleural fluid of patients with tuberculosis or cancer. Rev Mai Respir 1989:6:343-347.
39. Guzman J. Brass KJ. Costabel U: Malignant pleural effusions due to small cell carcinoma of the lung: An immunocytochemical cell surface analysis of lymphocytes and tumor cells. Acta Cytol 1990:34:497-501.
40. Ghosh AK. Spriggs AI. Mason DY: Immunocytochemical staining of I and B lymphocytes in serous effusions. J Clin Pathol 1985:38:608-612.
41. Katz RL, Raval P. Maning JT, McLaughlin P. Barlogie B: A morphologic, immunologic, and cytometric approach to the classification of non-Hodgkin’s lymphoma in effusions. Diagn Cytopathol 1987:3:91-101.
42. Pinto MM: DNA analysis of malignant effusions. Comparison with cytologic diagnosis and carcinoembryogenic antigen content. Anal Quant Cytol Histol 1992:14:222-226.
43. Mezger J, Lament R. Permanetter W: Diagnostic significance of carcinocmbryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorac Cardiovasc Surg 1990:100: 860-866.